A Study to Evaluate the Use of Platelet-rich Plasma to Treat Erectile Dysfunction

Overview

About this study

The purpose of this study is to develop and implement an innovative treatment for erectile dysfunction (ED).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • The patient must have given his informed and signed written consent.
  • The patient is a male.
  • Between 45 and 65 years of age.
  • The patient has ED for longer than 1 year but less than 5 years.
  • The patient is PDE5i responsive, meaning he is able to achieve and maintain an erection under the effect of the maximal dosage of PDE5i.
  • SHIM- EF Domain score of 17-20.
  • Evidence Based Criteria: Doppler Clinical Exam ( PSV < 35 cm/sec, but > 25 cm/sec and RI > 0.8).

Exclusion Criteria:

  • The patient is participating in another study that may interfere with the results or conclusions of this study.
  • History of radical prostatectomy or extensive pelvic surgery.
  • Past radiation therapy of the pelvic region within 12 months prior to enrollment.
  • Recovering from cancer within 12 months prior to enrollment.
  • Neurological disease which effects erectile function.
  • Psychiatric disease which effects erectile function.
  • The patient is taking blood thinners.
  • History of Diabetes Mellitus.
  • History of Coronary Artery Disease.
  • Evidence Based Criteria: Doppler Clinical Exam ( PSV > 35 cm/sec, < 25 cm/sec and RI < 0.8).
  • Biochemical evidence of Hypogonadism (total Testosterone < 300 ng/dL).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Gregory Broderick, M.D.

Open for enrollment

Contact information:

Rachel Pung Page

White.Rachel2@mayo.edu

More information

Publications

Publications are currently not available